1. Foreman Hogan MC,Ahn Naghavi M,Makela Wang M,Lozano Lopez AD (2010). Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millenium Development Goal 5. Lancet, 375, 1609-1623.
2. World Health Organization,U.N.C.F,United Nations Population Fund,World Bank (2007). Maternal Mortality in 2005. Estimates developed by WHO, UNICEF, UNFPA, and The World Bank. Maternal Mortality in 2005. Estimates developed by WHO, UNICEF, UNFPA
3. Natalia Novikova,G. Hofmeyr (2011). Novikova N, Hofmeyr GJ: Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev, 7, 7872.
4. Dunn CJ,Goa KL (1999). Tranexamic acid: a review of its use in surgery and other indications.Drugs. Drugs, 57(6), 1005-1032.
5. Roberts I,Shakur H,Coats T,Hunt B,Balogun E,Barnetson L (2013). The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess
6. Wellington K,Wagstaff AJ (2003). Tranexamic acid: a review of its use in the management of menorrhagia Drugs. Drugs, 63(13), 1417-1433.
7. Department of Reproductive Health and Research, World Health Organization Geneva: WHO Library Cataloguing- in-Publication Data NLM classification: WQ.
8. H. Abdel-Aleem,T. Alhusaini,M. Abdel-Aleem,M. Menoufy,A. Gülmezoglu (2013). Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. 2013 Nov, 26(17), 1705-1709.
9. Upasana Goswami,Sushmita Sarangi,Sunali Gupta,Savita Babbar (2013). Comparative evaluation of two doses of tranexamic acid used prophylactically in anemic parturients for lower segment cesarean section: A double-blind randomized case control prospective trial. Saudi Journal of Anaesthesia, 7(4), 427.
10. M. Gohel,P. Patel,G. Ashoo,P. Desai (2007). Efficacy of Tranexamic Acid in Decreasing Blood Loss during and after Cesarean Section: A Randomized Case Controlled Prospective Study.
11. Ming-Ying Gai,Lian-Fang Wu,Qi-Feng Su,Karin Tatsumoto (2004). Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. European Journal of Obstetrics & Gynecology and Reproductive Biology, 112(2), 154-157.
12. Gungorduk K,Yıldırım G,Asıcıoğlu O,Gungorduk OC,Sudolmus S,Ark C (2011). Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: A prospective, randomized, double-blind, placebo-controlled study Am J Perinatol.
13. Movafegh A,Eslamian L,Dorabadi A (2011). Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery. Int J Gynaecol Obstet, 115, 224-6.
14. Gao XuJ,Ju Y (2013). Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial Arch Gynecol Obstet. 2013 Mar, 287(3), 463-468.
15. A. Shahid,A. Khan (2013). Tranexamic acid in decreasing blood loss during and after caesarean section. J Coll Physicians Surg Pak, 23(7), 459-462.
16. Sentürk MB,Cakmak Y,Yildiz G,Yildiz P (2013). Tranexamic acid for cesarean section: a doubleblind, placebo-controlled, randomized clinical trial.Arch Gynecol Obstet. 2013 Apr, 287(4), 641-645.
17. (2011). High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Critical Care, R117.
18. (2012). Roberts I, Shakur H, Ker K, Coats T; CRASH-2 Trial collaborators.Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev, 4896.
19. (2010). The WOMAN trial (World Maternal Antifibrinolytic Trial): Tranexamic acid for the treatment of post partum haemorrhage: An international randomized, double blind placebo controlled trial. Trials, 11(1), 40.
